1.1 This test method provides a methodology to assess the cytotoxicity of suspensions of nanoparticulate materials in porcine proximal tubule cells (LLC-PK1) and human hepatocarcinoma cells (Hep G2) which represents potential target organs following systemic administration
1.2 This test method is part of the in vitro preclinical characterization cascade.
1.3 This test method consists of a protocol utilizing two methods for estimation of cytotoxicity, 3-(4,5-Dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) reduction and lactate dehydrogenase (LDH) release.
1.4 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
More ASTM standard pdf
ASTM D5772-10
Standard Test Method for Cloud Point of Petroleum Products (Linear Cooling Rate Method)
$30.00 $60.00
ASTM D5966-10
Standard Test Method for Evaluation of Engine Oils for Roller Follower Wear in Light-Duty Diesel Engine
$33.00 $67.00
ASTM A709/A709M-01b
Standard Specification for Carbon and High-Strength Low-Alloy Structural Steel Shapes, Plates, and Bars and Quenched-and-Tempered Alloy Structural Steel Plates for Bridges
$30.00 $60.00